Oncology data evolves and emerges at a rapid pace leading to a proliferation of new actionable mutations, therapeutic targets, new therapies, and changes in treatment sequencing. The Keeping Pace in Oncology CME series has been developed to synthesize the latest data from clinical trials to help community oncologists keep pace with the rapid changes and best practices for integrating advances into clinical practice. Educational modules feature conversations with leading experts to explore clinical insights and perspectives on patient-centered treatment.
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negative Metastatic Breast Cancer
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negative Metastatic Breast Cancer
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer